EUA
SynergyDx SARS-CoV-2 RNA Test DTC
FDA Emergency Use Authorization · Synergy Diagnostic Laboratory, Inc., DBA SynergyDx · Jun 2, 2021
Key facts
| Product | SynergyDx SARS-CoV-2 RNA Test DTC |
|---|---|
| Company | Synergy Diagnostic Laboratory, Inc., DBA SynergyDx |
| Product type | Direct to Consumer (DTC), Real-time RT-PCR, Home Collection, Screening, Multiple Targets |
| Date | Jun 2, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: